Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly ...

A new care center for homeless people on Los Angeles' infamous Skid Row embraces the principle of harm reduction, a more ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

GLP-1 drugs like Ozempic may have much more serious, and even potentially deadly, side effects than originally thought.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...

This follows a World Health Organization (WHO) assessment that highlighted major areas for improvement needed in India's drug ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...